Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1/2 1

Status

Unknown 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Prostatic Neoplasms 3Uterine Cervical Dysplasia 2Thyroid Nodule 2Sarcoma 2Papillomavirus Infections 2Melanoma 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Spinal Cord Compression 1Recurrence 1Prostatic Hyperplasia 1Precancerous Conditions 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Neoplasms 1Liver Neoplasms 1Hyperthyroidism 1HIV Infections 1Genital Neoplasms, Female 1Genital Diseases, Female 1Genital Diseases 1Gastrointestinal Neoplasms 1

Interventions

Sorafenib 202lenvatinib 129Bevacizumab 124Nivolumab 85pembrolizumab 72atezolizumab 72Radiosurgery 71durvalumab 63Oxaliplatin 59sintilimab 57Fluorouracil 54Doxorubicin 44tislelizumab 43apatinib 43Leucovorin 40tremelimumab 37camrelizumab 37Radiofrequency Ablation 37Radiotherapy 36Magnetic Resonance Spectroscopy 32Capecitabine 30regorafenib 29Folfox protocol 29Cisplatin 28cabozantinib 26Hepatectomy 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25toripalimab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Hepatocellular × Transurethral Resection of Prostate × Clear all
NCT06609876 2024-12-03

Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC

Sun Yat-sen University

Phase NA Recruiting
108 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT03864211 2022-09-29

Thermal Ablation Followed by Immunotherapy for HCC

Xiangya Hospital of Central South University

Phase 1/2 Unknown
145 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05240404 2022-02-15

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

Xiangya Hospital of Central South University

Phase 2 Unknown
116 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02630108 2016-10-18

TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma

Shanghai Zhongshan Hospital

Phase 3 Unknown
280 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡